Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 217S · 10 late217 trades$54.77M| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 18 | O Connor Kevin JDirector |  PCORPROCORE TECHNOLOGIES, INC.Open-market sale · 10b5-1 plan | SELL | $6,713 110 sh | Nov 4, 2026 |
| 18 | van Houte HansChief Financial Officer |  NRIXNurix Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $51K 3,300 sh | Nov 4, 2026 traded Nov 4, 2026 |
| 18 | Felice Laura L.EVP, Chief Financial Officer |  BJBJ's Wholesale Club Holdings, Inc.Open-market sale · 10b5-1 plan | SELL | $1.11M 10.0K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 18 | Peetz ChristopherDirector, CHIEF EXECUTIVE OFFICER |  MIRMMirum Pharmaceuticals, Inc.Open-market sale · 10b5-1 plan | SELL | $1.80M 20.0K sh | Nov 4, 2026 traded Nov 4, 2026 |
| 18 | Tsao DavidDirector, Chief Technology Officer | BLLNBillionToOne, Inc. Open-market sale · 10b5-1 plan | SELL | $353K 3,241 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 18 | Maetzold Derek JDirector, Pres. & Chief Exec. Officer |  CSTLCASTLE BIOSCIENCES INCOpen-market sale · 10b5-1 plan | SELL | $101K 2,816 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 18 | Tsao DavidDirector, Chief Technology Officer | BLLNBillionToOne, Inc. Open-market sale · 10b5-1 plan | SELL | $251K 2,320 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 18 | Tsuchimoto Kim RDirector |  MNPRMonopar TherapeuticsOpen-market sale · 10b5-1 plan | SELL | $43K 600 sh | Nov 4, 2026 traded Nov 4, 2026 |
| 18 | Atay OguzhanDirector, Chairman and CEO | BLLNBillionToOne, Inc. Open-market sale · 10b5-1 plan | SELL | $434K 4,009 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 18 | Maetzold Derek JDirector, Pres. & Chief Exec. Officer | CSTLCASTLE BIOSCIENCES INC Open-market sale · 10b5-1 plan | SELL | $86K 2,393 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 18 | Syrvalin Kristine CEVP General Counsel |  MTUSMetallus Inc.Open-market sale · 10b5-1 plan | SELL | $102K 4,643 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 17 | Palmer Benjamin EdwardSVP, Pres Commercial |  VSATVIASAT INCOpen-market sale · 10b5-1 plan | SELL | $154K 2,000 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 17 | Kleinerman ChristianEVP, Product Management | SNOWSnowflake Inc. Open-market sale · 10b5-1 plan | SELL | $3.06M 10.0K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 17 | Hancock MarkDirector, 10% Owner |  PACSPACS Group, Inc.Open-market sale · 10b5-1 plan | SELL | $8.81M 174.9K sh | Nov 4, 2026 traded Nov 4, 2026 |
| 17 | Murray Jason HulseDirector, Co-Founder, CEO & Chairman, 10% Owner | PACSPACS Group, Inc. Open-market sale · 10b5-1 plan | SELL | $6.71M 133.3K sh | Nov 4, 2026 traded Nov 4, 2026 |
| 17 | Wassenaar YvonneDirector | RBRKRubrik, Inc. Open-market sale · 10b5-1 plan | SELL | $84K 721 sh | Nov 4, 2026 traded Nov 4, 2026 |
| 17 | Murray Jason HulseDirector, Co-Founder, CEO & Chairman, 10% Owner | PACSPACS Group, Inc. Open-market sale · 10b5-1 plan | SELL | $1.34M 29.1K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 17 | Stat Lauren Elaina FriedmanDirector | PLTRPalantir Technologies Inc. Open-market sale · 10b5-1 plan | SELL | $253K 1,358 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 17 | Hendry Gregory LChief Accounting Officer |  PMTPennyMac Mortgage Investment TrustOpen-market sale · 10b5-1 plan | SELL | $19K 2,443 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 17 | Tsuchimoto Kim RDirector | MNPRMonopar Therapeutics Open-market sale · 10b5-1 plan | SELL | $92K 1,295 sh | Nov 4, 2026 traded Nov 4, 2026 |
| 17 | Anderson RaymondDirector | MNPRMonopar Therapeutics Open-market sale · 10b5-1 plan | SELL | $56K 840 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 17 | Puri Michal NathChief Human Resources Officer |  NVCRNovoCure LtdOpen-market sale | SELL | $8,738 660 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Kasbar Michael JDirector, Executive Chairman |  WKCWORLD KINECT CORPOpen-market sale · 10b5-1 plan | SELL | $292K 8,062 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Rabinowitz DanielSEC. AND CHIEF LEGAL OFFICER | NTRANatera, Inc. Open-market sale · 10b5-1 plan | SELL | $134K 334 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Brophy Michael BurkesCHIEF FINANCIAL OFFICER | NTRANatera, Inc. Open-market sale · 10b5-1 plan | SELL | $127K 317 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | NTRANatera, Inc. Open-market sale · 10b5-1 plan | SELL | $100K 240 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Coloma Jason VDirector, Chief Executive Officer | MAZEMaze Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $799K 26.6K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Vassil JonathanChief Revenue Officer |  TOSTToast, Inc.Open-market sale · 10b5-1 plan | SELL | $373K 11.1K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Brophy Michael BurkesCHIEF FINANCIAL OFFICER | NTRANatera, Inc. Open-market sale · 10b5-1 plan | SELL | $184K 470 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 16 | Bhutani Amanpal SinghDirector, Chief Executive Officer |  GDDYGoDaddy Inc.Open-market sale · 10b5-1 plan | SELL | $530K 4,500 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | NTRANatera, Inc. Open-market sale · 10b5-1 plan | SELL | $81K 200 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | NTRANatera, Inc. Open-market sale · 10b5-1 plan | SELL | $213K 520 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | NTRANatera, Inc. Open-market sale · 10b5-1 plan | SELL | $166K 408 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | NTRANatera, Inc. Open-market sale · 10b5-1 plan | SELL | $176K 432 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | NTRANatera, Inc. Open-market sale · 10b5-1 plan | SELL | $164K 410 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Fesko JohnPRESIDENT, CHIEF BUS. OFFICER | NTRANatera, Inc. Open-market sale · 10b5-1 plan | SELL | $118K 295 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Nonko EugeneDirector | MAXMediaAlpha, Inc. Open-market sale · 10b5-1 plan | SELL | $1.43M 93.3K sh | Nov 4, 2026 traded Nov 4, 2026 |
| 16 | Yi StevenDirector, See Remarks | MAXMediaAlpha, Inc. Open-market sale · 10b5-1 plan | SELL | $2.34M 151.1K sh | Nov 4, 2026 traded Nov 4, 2026 |
| 16 | Yi StevenDirector, See Remarks | MAXMediaAlpha, Inc. Open-market sale · 10b5-1 plan | SELL | $1.96M 130.1K sh | Nov 4, 2026 traded Nov 3, 2026 |
| 16 | Leach BryanDirector, CEO AND PRESIDENT, 10% Owner |  IBTAIbotta, Inc.Open-market sale · 10b5-1 plan | SELL | $63K 1,129 sh | Nov 4, 2026 traded Nov 3, 2026 |
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
FERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
IBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
ARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
BBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K
BCYCBICYCLE THERAPEUTICS PLCOct 2 – Oct 56 insiders$63K